Xenetic Biosciences, Inc. to Present at the Virtual Investor NETs in Cancer Spotlight Event
Xenetic Biosciences, Inc. Announces Notice of Allowance for Canadian Patent Covering Use of DNase Enzyme for Preventing or Ameliorating Toxicity Associated with Chemotherapy
Xenetic Biosciences, Inc. to Present at the Virtual Investor 2023 Companies to Watch Event
